LATEST NEWS
EXACT Therapeutics completed the dose escalation part of ACTIVATE study
EXACT Therapeutics receives regulatory approval to start the dose expansion part of ACTIVATE study
ICR London and EXACT Therapeutics in collaborating project
CEO Per Walday present EXACT Therapeutics at ABGSC Life Science Summit 2023
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer